medigraphic.com
SPANISH

Medicina Crítica

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • Policies
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 4

<< Back

Med Crit 2022; 36 (4)

Coccidioidomycosis in a COVID-19 patient. A case report in the Intensive Care Unit

Armenta SK, Pacheco AD
Full text How to cite this article 10.35366/105797

DOI

DOI: 10.35366/105797
URL: https://dx.doi.org/10.35366/105797

Language: Spanish
References: 9
Page: 249-253
PDF size: 263.66 Kb.


Key words:

Coccidioidomycosis, COVID-19, endemic, coinfection.

ABSTRACT

Introduction: Coccidioidomycosis and COVID-19 are classified as primary pulmonary pathologies. Both present a nonspecific initial picture, however, in advanced phases they may require hospitalization, ventilatory support and admission to the intensive care unit, manifesting with a severe acute respiratory failure syndrome. Clinical case: The case of a female patient who is admitted to the intensive care unit for presenting severe SIRA due to COVID-19 is described, however, she presents a torpid evolution so her diagnostic approach is continued, finding coccidioidomycosis as a finding as coexisting disease. This being the first case reported in Mexico in a critical medicine journal. Conclusion: The diagnosis of coccidioidomycosis is even more complex because it can go unnoticed, losing the opportunity for an early diagnosis and this is related to a poor subsequent evolution as it happened in our case.


REFERENCES

  1. Kollath DR, Miller KJ, Barker BM. The mysterious desert dwellers: Coccidioides immitis and Coccidioides posadasii, causative fungal agents of coccidioidomycosis. Virulence. 2019;10(1):222-233. doi: 10.1080/21505594.2019.1589363.

  2. Shah AS, Heidari A, Civelli VF, Sharma R, Clark CS, Munoz AD, et al. The coincidence of 2 epidemics, coccidioidomycosis and SARS-CoV-2: a case report. J Investig Med High Impact Case Rep. 2020;8:2324709620930540.

  3. Heaney AK, Head JR, Broen K, Click K, Taylor J, Balmes JR, et al. Coccidioidomycosis and COVID-19 co-infection, United States, 2020. Emerg Infect Dis. 2021;27(5):1266-1273. Available in: http://dx.doi.org/10.3201/eid2105.204661

  4. Chang CC, Senining R, Kim J, Goyal R. An acute pulmonary coccidioidomycosis coinfection in a patient presenting with multifocal pneumonia with COVID-19. J Investig Med High Impact Case Rep. 2020;8:2324709620972244.

  5. Adams M, Lainhart W. A review of diagnostics for coccidiomycosis. Clin Microbiol Newsl. 2021;43(16):135-141.

  6. Krauth DS, Jamros CM, Rivard SC, Olson NH, Maves RC. Accelerated progression of disseminated coccidioidomycosis following SARS-CoV-2 infection: a case report. Mil Med [Internet]. 2021;186(11-12):1254-1256. Available in: http://dx.doi.org/10.1093/milmed/usab132

  7. Adam RD, Elliott SP, Taljanovic MS. The spectrum and presentation of disseminated coccidioidomycosis. Am J Med. 2009;122(8):770-777.

  8. Voronina A, Prudenti J, Castaneda C, Tong J, Gumpeni R. A cryptic case of coccidioidomycosis masquerading as lung cancer. In: C54. Endemic and unusual fungal infection cases. Am J Respir Crit Care Med. 2020;201:A5480.

  9. Porte L, Valdivieso F, Wilmes D, Gaete P, Díaz MC, Thompson L, et al. Laboratory exposure to Coccidioides: lessons learnt in a non-endemic country. J Hosp Infect. 2019;102(4):461-464.




Figure 1
Figure 2
Figure 3
Figure 4

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Crit. 2022;36